Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Diclofenac Sodium Articles

World Immunology, Rheumatology Markets

28 November 1994

DDT's New Global Pharma Market Review 1994

10 October 1994

Ciba Performs Well But Hit By Currencies

5 September 1994

Injunction Against Novopharm

8 August 1994

WHAT FUTURE FOR STERLING HEALTH

4 July 1994

ITALIAN POLICE SEIZE ILLICIT DRUGS MONEY

27 June 1994

EUROPEAN PHARMA ISSUES ASSESSED BY IMS

30 May 1994

STRONG SWISS FRANCS HITS CIBA'S 1st QTR

25 April 1994

CIBA RESULTS FOR 1993 "AS PROMISED"

4 April 1994

EFFECTS OF JAPAN NHI PRICE CUTS

7 March 1994

CIBA LAUNCHES CATAFLAM NSAID IN USA

31 January 1994

MUSCULOSKELETAL MARKET TO DECLINE

6 December 1993

STRUCTURAL CHANGES AT CIBA

22 November 1993

US DRUGSTORE AUDIT DATA FOR JULY

6 September 1993

MISOPROSTOL PRAISED AT ILAR

26 July 1993

INDIA: A PATENT REGIME FOR DRUG SECURITY

21 June 1993

THREE-WAY GENERIC AGREEMENT

31 May 1993

CIBA'S 1992 HEALTH CARE PROFITS SQUEEZED

5 April 1993

1ST LAUNCH OF ARTHROTEC IN UK

8 February 1993

GLOBAL DRUG MARKET: 30 YEARS OF GROWTH

4 January 1993

US OTC ANALGESICS - A 1992 RETROSPECTIVE

4 January 1993

ANALYSTS ASSESS CIBA'S PHARMA PROSPECTS

9 November 1992

SEARLE'S ARTHROTEC APPROVED IN UK

22 June 1992

SANOFI, CIBA-GEIGY ON PARIBAS BUY LIST

13 January 1992

ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?

6 January 1992

Showing 101-125 of 125 articles

Go to beginningPrevious
  • 1
  • 2
NextGo to end
  • Hot Topics
  • Most Read
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS